emerg
new
pathogen
middl
east
respiratori
syndrom
coronaviru
merscov
pose
seriou
challeng
global
public
health
highlight
urgent
need
method
rapidli
identifi
character
potenti
therapeut
prevent
option
neutral
antibodi
spike
protein
present
surfac
merscov
virion
mediat
viral
entri
primari
target
merscov
vaccin
antibodi
develop
becom
increasingli
import
understand
merscov
antibodi
bind
specif
function
commonli
use
serolog
method
like
elisa
biolay
interferometri
flow
cytometri
inform
limit
demonstr
highthroughput
protein
bind
inhibit
assay
use
imag
cytometri
imag
cytometrybas
highthroughput
screen
method
develop
select
cell
type
high
express
defin
optim
seed
densiti
protein
bind
condit
abil
monoclon
antibodi
inhibit
merscov
bind
test
bind
inhibit
result
compar
describ
previou
literatur
merscov
spike
monom
show
similar
pattern
neutral
result
coeffici
variat
cv
cellbas
assay
propos
imag
cytometri
method
provid
effici
approach
character
potenti
therapeut
antibodi
combat
merscov
compar
favor
current
method
abil
rapidli
determin
direct
antibodi
bind
host
cell
highthroughput
manner
appli
studi
pathogenantibodi
interact
thu
impact
futur
research
viral
pathogen
niu
et
al
wang
et
al
wang
et
al
yu
et
al
howev
previou
public
also
describ
neutral
ntdand
monoclon
antibodi
mab
chen
et
al
http
doi
coronavirus
cov
thrive
anim
reservoir
repres
constant
threat
human
health
six
cov
current
known
infect
human
four
circul
endem
caus
rel
mild
respiratori
diseas
rare
lethal
corman
et
al
zoonot
transmiss
cov
associ
high
mortal
exemplifi
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
global
merscov
result
laboratoryconfirm
case
infect
fatal
statist
increas
viru
continu
caus
outbreak
middl
east
frequent
region
outbreak
pandem
potenti
merscov
support
need
prophylact
therapeut
intervent
monoclon
antibodi
broad
neutral
activ
could
use
purpos
merscov
virion
display
surfac
spike
protein
two
compon
protom
includ
head
region
facilit
viral
attach
stem
region
contain
fusion
machineri
merscov
compartment
receptorbind
domain
rbd
bind
host
cell
receptor
dipeptidyl
ntermin
domain
ntd
raj
et
al
wang
et
al
sinc
rbd
involv
receptor
bind
mani
antibodi
approach
thu
far
focus
merscov
rbd
subunit
corti
et
al
johnson
et
al
corti
et
al
wang
et
al
wang
et
al
recent
structur
elucid
fulllength
merscov
trimer
pallesen
et
al
yuan
et
al
addit
antibodi
target
becom
feasibl
includ
region
subunit
quaternari
epitop
expos
heptad
repeat
region
subunit
mani
monoclon
igg
show
promis
anim
challeng
model
chen
et
al
corti
et
al
johnson
et
al
wang
et
al
wang
et
al
polyclon
igg
render
safe
toler
phase
clinic
trial
beigel
et
al
still
merscovspecif
antibodi
product
approv
noninvestig
human
use
merscov
rbdspecif
antibodi
work
block
receptor
bind
subsequ
prevent
infect
yu
et
al
hypothet
nonrbd
antibodi
work
steric
block
receptor
bind
interfer
protein
rearrang
prevent
membran
fusion
inhibit
downstream
infect
event
includ
fcmediat
effector
function
overal
mechan
action
merscov
antibodi
fulli
understood
dawn
novel
merscov
vaccin
antibodi
develop
increasingli
import
understand
merscov
antibodi
interact
context
entir
protein
end
develop
new
assay
measur
antibodi
interact
function
advanc
field
current
merscov
antibodi
function
studi
two
broad
perspect
bind
neutral
antibodi
bind
typic
studi
via
method
elisa
biolay
interferometri
fluorescenceactiv
cell
sort
fac
neutral
often
assess
via
pseudoviru
report
plaqu
reduct
neutral
prnt
assay
immort
cell
perera
et
al
zhao
et
al
elisa
assay
limit
inabl
reliabl
assess
antibodi
bind
protein
antigen
nativ
conform
therefor
elisa
data
sometim
mislead
potenti
gener
falseposit
result
exampl
fulllength
merscov
known
variabl
rbd
conform
pallesen
et
al
yuan
et
al
may
differenti
bind
certain
antibodi
unlimit
access
epitop
elisa
bind
conformationallydepend
rbdspecif
antibodi
may
exagger
altern
elisa
biolay
interferometri
util
tag
antigen
bound
affin
tip
although
method
may
promot
uniform
protein
orient
limit
requir
tag
protein
immobil
affin
tip
addit
previou
public
also
shown
biolay
interferometri
may
reduc
sensit
reproduc
yang
et
al
major
merscov
antibodi
function
inhibit
bind
date
best
studi
fac
pallesen
et
al
wang
et
al
fac
method
util
authent
fold
protein
cell
surfac
howev
cytomet
rel
expens
sophist
instrument
requir
manag
highlytrain
specialist
ongo
mainten
servic
engin
fac
also
requir
timeconsum
warmup
procedur
laser
calibr
clean
use
therefor
identifi
new
method
rapidli
effect
measur
antibodi
bind
function
properti
facilit
evalu
screen
antibodi
merscov
pathogen
go
forward
highthroughput
cellbas
antibodi
bind
assay
establish
use
celigo
imag
cytomet
riedl
et
al
zhang
et
al
abil
directli
imag
analyz
protein
antibodi
bind
target
cell
allow
research
character
bind
affin
cell
surfac
antigen
platebas
imag
cytometri
captur
analyz
bright
field
fluoresc
imag
fluoresc
antibodylabel
cell
directli
micropl
thu
elimin
need
disturb
natur
state
cell
method
lyse
trypsin
imag
cytometri
workflow
requir
special
materi
timeconsum
mainten
procedur
perform
imag
analysi
herein
develop
highthroughput
protein
bind
inhibit
assay
use
celigo
imag
cytomet
select
cell
type
defin
seed
densiti
merscov
protein
bind
condit
optim
concentr
fluoresc
stain
evalu
three
monoclon
antibodi
recogn
merscov
rbd
ntd
respect
bind
inhibit
merscov
cell
final
quantifi
abil
three
mab
neutral
merscov
pseudoviru
infect
describ
assay
facilit
rapid
measur
protein
bind
cell
highthroughput
manner
imag
cytometri
method
simpl
highthroughput
effici
good
reproduc
dynam
rang
ultim
method
use
character
potenti
therapeut
antibodi
merscov
pathogen
huh
kindli
provid
provid
deborah
r
taylor
us
food
drug
administr
silver
spring
md
cell
maintain
co
modifi
eagl
medium
supplement
vv
fetal
bovin
serum
penicillin
streptomycin
growth
media
cell
plate
overnight
variou
plasmid
encod
fulllength
human
transfect
cell
use
lipofectamin
reagent
invitrogen
carlsbad
ca
follow
manufactur
instruct
two
day
transfect
cell
fix
stain
imag
cytometri
analysi
determin
express
level
cell
nuclei
stain
dapi
receptor
stain
peconjug
mous
antibodi
sino
biolog
wayn
pa
unconjug
rabbit
polyclon
anitbodi
abcam
cambridg
follow
antirabbit
antibodi
label
alexa
abcam
fluoresc
data
export
multipl
fc
file
flow
softwar
analysi
express
level
analyz
combin
imag
cytomet
flowjo
softwar
tree
star
san
carlo
ca
cell
seed
flat
bottom
blackwal
greiner
plate
greiner
cellstar
cellswel
media
allow
adher
reach
confluenc
overnight
follow
day
cell
transfect
express
plasmid
use
lipofectamin
reagent
two
day
follow
transfect
prefusionstabil
merscov
protein
pallesen
et
al
incub
serial
dilut
antibodi
min
room
temperatur
rt
mixtur
merscov
mab
ad
cell
incub
h
rt
incub
cell
wash
pb
fix
cold
aceton
min
rt
wash
pb
subsequ
merscov
rabbit
polyclon
antibodi
sino
biolog
beij
china
pipet
well
incub
min
rt
wash
twice
next
secondari
goat
antirabbit
igg
h
l
peconjug
mous
antibodi
sino
biolog
ad
incub
min
rt
wash
twice
final
cell
stain
nm
dapi
min
wash
time
prior
imag
cytometr
analysi
nativ
cell
cell
surfac
serv
neg
control
experi
dapi
pe
stain
serv
intern
control
cell
growth
express
respect
imag
cytometri
data
export
multipl
fc
file
flowjo
analysi
well
level
data
graphpad
prism
analysi
fluoresc
intens
data
gate
flowjo
determin
percent
inhibit
percent
inhibit
respect
mab
concentr
plot
analyz
use
graphpad
prism
onesitefit
logic
nonlinear
regress
analysi
inhibit
defin
merscov
bind
without
addit
mab
full
inhibit
defin
merscov
bind
without
receptor
sigmoid
dose
respons
curv
log
mab
concentr
versu
percent
inhibit
gener
ic
valu
calcul
pseudoviru
neutral
assess
cell
plate
overnight
white
plate
transfect
day
serial
dilut
mab
start
nm
fourfold
eight
dilut
serumfre
dmem
mix
merscov
pseudoviru
made
titer
target
rel
luciferas
unit
rlu
per
previouslydescrib
method
pallesen
et
al
wang
et
al
incub
min
rt
media
aspir
previouslypl
cell
mabpseudoviru
mixtur
ad
viru
allow
transduc
cell
h
fresh
growth
media
ad
cell
lyse
h
firefli
luciferas
substrat
promega
madison
wi
ad
per
manufactur
protocol
rel
luciferas
unit
rlu
measur
nm
spectramaxl
luminomet
molecular
devic
san
jose
ca
sigmoid
curv
plot
rlu
averag
duplic
fifti
percent
neutral
ic
titer
calcul
consid
uninfect
cell
neutral
cell
transduc
pseudoviru
neutral
celigo
imag
cytomet
demonstr
mani
highthroughput
cellbas
assay
chan
et
al
zhang
et
al
imag
cytometri
instrument
util
transmiss
epifluoresc
setup
one
brightfield
bf
four
fluoresc
fl
imag
channel
blue
green
red
far
red
high
power
led
perform
platebas
imag
cytometr
analysi
celigo
softwar
use
applic
target
mask
target
mask
identifi
dapistain
target
cell
blue
channel
measur
fluoresc
intens
peconjug
mous
antibodi
red
channel
goat
antirabbit
igg
h
l
green
channel
measur
fluoresc
intens
result
export
flowjo
analysi
express
merscov
bind
inhibit
cell
stain
micropl
load
analyz
celigo
use
preset
scan
analyz
set
express
analysi
celigo
setup
acquir
imag
target
bright
field
target
red
pe
mask
blue
dapi
exposur
time
respect
merscov
bind
inhibit
analysi
celigo
setup
acquir
imag
target
bright
field
target
green
alexa
target
red
pe
mask
blue
dapi
exposur
time
respect
next
hardwarebas
autofocu
hwaf
select
focu
cell
bright
field
channel
focu
offset
appli
green
blue
red
channel
subsequ
target
well
select
imag
acquisit
imag
acquisit
imag
analysi
perform
simultan
preset
analyz
paramet
use
identifi
dapistain
target
cell
mask
next
mask
appli
green
pe
red
fluoresc
channel
analyz
fluoresc
intens
well
fluoresc
intens
result
directli
export
multipl
fc
file
flowjo
analysi
ic
valu
bind
inhibit
determin
use
graphpad
prism
import
note
fluoresc
readout
celigo
base
mean
fluoresc
intens
mfi
correspond
imag
pixel
intens
rang
translat
fluoresc
histogram
scale
flowjo
merscov
util
entri
receptor
host
cell
merscov
protein
use
investig
inhibit
merscov
bind
host
cell
variou
antibodi
maxim
signal
merscov
bind
receptor
express
target
cell
high
concentr
test
cell
type
transfect
assay
perform
differ
concentr
dna
rang
concentr
produc
highest
express
select
respect
fig
show
visual
comparison
express
cell
left
panel
display
untransfect
cell
right
panel
illustr
highest
transfect
cell
type
fluoresc
intens
analysi
use
flowjo
shown
fig
express
least
effici
cell
posit
follow
transfect
cell
cell
approxim
cell
thu
chosen
experi
addit
cell
known
endogen
receptor
therefor
cell
without
transfect
serv
neg
control
experi
import
optim
cell
seed
densiti
maxim
fluoresc
signal
without
overcrowd
avoid
signal
quench
purpos
differ
densiti
cell
cellswel
seed
overnight
transfect
densiti
rang
select
transfect
protocol
plate
suggest
use
cellswel
addit
base
previou
experi
seed
cellswel
lower
result
dim
signal
two
day
posttransfect
cell
confluenc
morpholog
visual
analyz
use
bright
field
analysi
fig
visual
cellswel
render
overcrowded
fig
cellswel
appear
spars
fig
cellswel
present
optim
seed
densiti
overlap
cell
even
distribut
throughout
well
fig
next
step
assay
develop
determin
optim
condit
bind
target
protein
cell
optim
condit
sever
paramet
test
protein
construct
merscov
trimer
monom
protein
amount
stain
protocol
antihistag
ab
differ
merscov
monoclon
ab
antimerscov
spike
ab
determin
merscov
solubl
trimer
antimerscov
spike
ab
produc
best
bind
result
data
shown
measur
protein
bind
cell
merscov
trimer
monom
test
protein
bound
effici
cell
fig
b
howev
flowjo
analysi
imagebas
fluoresc
intens
data
indic
merscov
trimer
fig
show
larger
peak
shift
mfi
right
shift
compar
monom
mfi
right
shift
fig
addit
util
merscov
fulllength
trimer
allow
evalu
antibodi
interact
entir
protein
therefor
merscov
trimer
select
subsequ
inhibit
experi
antirbd
antibodi
domin
host
immun
respons
vaccin
merscov
immunogen
block
bind
rbdspecif
antibodi
neutral
viral
entri
host
cell
antibodi
also
rais
epitop
includ
ntd
region
use
mab
bind
differ
region
merscov
measur
abil
inhibit
merscov
bind
cell
rbdspecif
fig
b
ntdspecif
data
shown
inhibit
merscov
bind
dosedepend
manner
phenomenon
exemplifi
fluoresc
intens
merscov
decreas
increas
mab
concentr
fig
b
bind
region
merscov
decreas
fluoresc
intens
attribut
bind
merscov
mab
prevent
merscov
bind
express
cell
bind
ntd
region
merscov
adjac
rbd
neighbor
protom
although
bind
footprint
overlap
data
suggest
inhibit
bind
merscov
unknown
mechan
plausibl
steric
interfer
interact
influenc
merscov
structur
stabil
bind
inhibit
curv
reveal
fig
fig
mab
ic
valu
nm
suggest
compar
bind
constant
merscov
result
correl
previou
biolay
interferometri
experi
show
mab
bound
merscov
confirm
bind
interact
measur
imag
cytomet
specif
merscov
bind
util
bind
region
spatial
distant
interact
thu
exhibit
inhibit
effect
expect
fig
three
mab
test
previous
shown
effect
neutral
merscov
pseudoviru
huh
cell
nativ
express
result
inhibit
assay
show
mab
inhibit
merscov
bind
cell
similar
ic
valu
mab
sinc
bind
region
presum
neutral
prevent
attach
neutral
experi
perform
determin
whether
neutral
pattern
also
similar
cell
expect
compar
neutral
curv
fig
ic
valu
nm
rang
reciproc
ic
neutral
potenc
fig
determin
one
order
magnitud
higher
recapitul
bind
inhibit
result
order
magnitud
differ
previous
shown
huh
cell
measur
antibodi
specif
magnitud
function
critic
develop
merscov
therapi
vaccin
current
assay
measur
ab
bind
neutral
limit
develop
altern
highthroughput
assay
base
bind
nativ
protein
conform
context
cell
would
use
result
demonstr
imag
cytometrybas
protein
bind
inhibit
assay
use
surrog
ic
determin
antibodi
character
design
assay
result
robust
method
measur
protein
bind
antibodi
protein
ligand
assess
bind
competit
variabl
newlydevelop
assay
assess
includ
duplic
triplic
within
experi
repeat
ident
paramet
differ
experi
coeffici
varianc
within
fig
merscov
protein
bind
cell
whole
well
fluoresc
imag
merscov
merscov
b
protein
bind
cell
monom
trimer
protein
stain
antimerscov
polyclon
demonstr
bind
cell
green
flowjo
analysi
imagebas
fluoresc
intens
data
merscov
monom
c
trimer
show
peak
shift
result
bind
experi
lower
experi
less
tabl
bind
inhibit
assay
combin
highthroughput
benefit
elisa
protein
conform
advantag
flow
cytometri
studi
efficaci
transfect
examin
start
point
assay
optim
transfect
effici
measur
mean
red
fluoresc
intens
associ
sever
cell
type
note
imag
cytometri
method
imag
cytomet
combin
direct
conjug
antibodi
sensit
enough
detect
low
level
endogen
fig
qualit
analysi
fluorescencebas
transfect
rapid
quantif
requir
imag
analysi
softwar
perform
manual
flow
cytometri
system
adapt
autom
data
acquisit
analysi
imag
cytomet
design
acquir
analyz
fluoresc
imag
highthroughput
manner
transfect
seen
captur
imag
level
transfect
could
analyz
intern
imag
cytometri
softwar
extern
fac
analysi
softwar
flowjo
yield
similar
result
minim
background
fluoresc
signal
observ
neg
control
group
also
initi
experi
optim
express
differ
cell
type
complet
parallel
flow
cytometri
acquisit
similar
result
data
shown
suggest
imag
cytometri
method
provid
compar
data
fac
simpler
format
requir
less
equip
mainten
flow
cytomet
imag
cytometri
abil
analyz
content
entir
well
facilit
rapid
optim
assay
develop
assay
fig
abil
mab
inhibit
merscov
protein
bind
cell
inhibit
merscov
bind
mab
measur
imag
cytometri
fluoresc
intens
analyz
flowjo
histogram
b
neg
control
nonrelev
isotyp
mab
use
dose
respons
curv
log
mab
concentr
versu
percent
inhibit
gener
c
e
mab
ce
dot
repres
duplic
error
bar
repres
sem
paramet
optim
rapidli
compar
flow
cytometri
seed
densiti
cell
type
protein
select
stain
method
consequ
propos
imag
cytometri
method
reduc
experiment
cost
allow
multipl
replic
variou
comparison
singl
plate
scan
sampl
plate
requir
min
gener
result
cell
count
cell
morpholog
fluoresc
express
total
count
includ
nontransfect
cell
area
mean
integr
fluoresc
intens
result
demonstr
imag
cytometri
enabl
rapid
assay
develop
result
highthroughput
assay
measur
merscovspecif
antibodi
function
propos
imag
cytometri
method
appli
studi
pathogenantibodi
interact
thu
valuabl
tool
infecti
diseas
research
gener
work
support
intramur
fund
nation
institut
allergi
infecti
diseas
support
work
vrc
bsg
nw
jsm
bsg
ksc
inventor
us
patent
applic
entitl
prefus
coronaviru
spike
protein
use
lw
ws
yz
wpk
bsg
inventor
us
patent
applic
entitl
middl
east
respiratori
syndrom
coronaviru
immunogen
antibodi
use
fig
abil
mab
neutral
merscov
cell
exogenouslyexpress
neutral
merscov
pseudoviru
red
blue
black
cell
neutral
titer
ic
calcul
base
sigmoid
curv
dot
repres
duplic
error
bar
repres
sem
